PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple myeloma |
| Symptom | C0035078|renal failure |
| Sentences | 28 |
| PubMedID- 26390728 | Dialysis-dependent renal failure in patients with multiple myeloma: reversibility factors. |
| PubMedID- 21339749 | renal failure in multiple myeloma: a medical emergency. |
| PubMedID- 25089594 | Bortezomib improves outcome after sct in multiple myeloma patients with end-stage renal failure. |
| PubMedID- 26154652 | The cases include non-adherent patients who discontinued their immunosuppressive medications, transplantation between identical twins, kidney transplantation after a successful bone marrow graft from the same donor and simultaneous bone marrow and kidney transplantation for the treatment of multiple myeloma with associated renal failure. |
| PubMedID- 23249872 | renal failure in multiple myeloma is frequent, and portends a dismal prognosis. |
| PubMedID- 25018923 | Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide. |
| PubMedID- 20955270 | Our systematic review does not suggest a benefit of plasmapheresis independent of chemotherapy for multiple myeloma patients with acute renal failure in terms of overall survival, recovery from dialysis, or improvement in renal function. |
| PubMedID- 22260636 | Background: the aim of this cross-sectional study was to evaluate multiple myeloma patients presenting with renal failure in a university hospital. |
| PubMedID- 25816886 | Chemotherapy with or without plasmapheresis in acute renal failure due to multiple myeloma: a meta-analysis. |
| PubMedID- 21511832 | Myeloma kidney is the major cause of severe irreversible renal failure in patients with multiple myeloma. |
| PubMedID- 21368487 | Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure. |
| PubMedID- 22889516 | Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy. |
| PubMedID- 23656195 | Down-regulation of microrna-29c is associated with renal failure in multiple myeloma. |
| PubMedID- 25671952 | Conclusions: iss stage and renal failure due to multiple myeloma at presentation have a significant impact on survival. |
| PubMedID- 23712232 | Effectiveness of haemodiafiltration with ultrafiltrate regeneration in renal failure due to multiple myeloma. |
| PubMedID- 26124916 | Immunoglobulin d multiple myeloma with rapidly progressing renal failure. |
| PubMedID- 25329484 | Evolving treatments in multiple myeloma patients with renal failure. |
| PubMedID- 26022018 | renal failure in patients with multiple myeloma. |
| PubMedID- 21188171 | There were two grade 4 renal failures in patients with multiple myeloma (mm). |
| PubMedID- 23350020 | Approximately 10% of these patients will either be dialysis-dependent or require dialysis.9 patients with multiple myeloma associated with renal failure generally have a worse prognosis due to a more aggressive disease and a reduced quality of life caused by increased complications.1,14 therefore, it is especially important in myeloma patients to find methods to reduce flc levels in the body. |
| PubMedID- 25285800 | Efficacy, toxicity and mortality of autologous sct in multiple myeloma patients with dialysis-dependent renal failure. |
| PubMedID- 20689322 | Background: the presence of renal failure in patients with multiple myeloma (mm) has been considered an ominous prognostic factor associated with a significantly decreased life expectancy. |
| PubMedID- 24895606 | Early articles linked iv administration of contrast agents with the development of renal failure in patients with multiple myeloma, leading to the conclusion that iv contrast media are contraindicated in patients with myeloma because they are at a high risk for developing cin . |
| PubMedID- 21264915 | High-dose glucocorticoids improve renal failure reversibility in patients with newly diagnosed multiple myeloma. |
| PubMedID- 23705905 | Current treatments for renal failure due to multiple myeloma. |
| PubMedID- 23597473 | Clinical study of bortezomib in the treatment of multiple myeloma patients with renal failure. |
| PubMedID- 19693498 | Reversal of dialysis-dependent renal failure in patients with advanced multiple myeloma: single institutional experiences over 8 years. |
| PubMedID- 23591252 | Cast nephropathy is one of the major causes of renal failure in patients with multiple myeloma resulting from precipitation of free light chains inside the tubules. |
Page: 1